Association of killer cell immunoglobulin-like receptor gene 2DL1 and its HLA-C2 ligand with family history of cancer in oral squamous cell carcinoma

Immunogenetics

Volumn 66, Issue 7-8, 2014, Pages 439-448

  Dutta, Anupam ^a   Saikia, Nabajyoti ^b   Phookan, Jyotirmoy ^c   Baruah, Munindra Narayan ^d   Baruah, Shashi ^a  

^a TEZPUR UNIVERSITY   (India)

^b ASSAM MEDICAL COLLEGE   (India)

^c GAUHATI MEDICAL COLLEGE   (India)

^d Department of ENT North East Cancer Hospital and Research Institute ^*  (India)

Author keywords

Family history of cancer; Human leukocyte antigen; Killer cell immunoglobulin like receptors; Oral squamous cell carcinoma; Tibeto Burman

Indexed keywords

HLA C ANTIGEN; HLA C2 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; FIRST DEGREE RELATIVE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GROUPS BY AGE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SECOND DEGREE RELATIVE; THIRD DEGREE RELATIVE; TUMOR LOCALIZATION;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; HLA-C ANTIGENS; HUMANS; LIGANDS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; RECEPTORS, KIR2DL1; RECEPTORS, KIR2DL3; RNA, MESSENGER; RNA, NEOPLASM;

EID: 84904260211     PISSN: 00937711     EISSN: 14321211     Source Type: Journal    
DOI: 10.1007/s00251-014-0778-1     Document Type: Article

References (30)

1. Al Omar YS, Marshall E, Middleton D, Christmas SE (2011) Increased killer immunoglobulin-like receptor expression and functional defects in natural killer cells in lung cancer. Immunology 133:94-104
2. Ashouri E, Ghaderi A, Reed EF, Rajalingam R (2009) A novel duplex SSP-PCR typing method for KIR gene profiling. Tissue Antigens 74:62-67
3. Barnes L, Eveson JW, Reichart P, Sidransky D (2005) Pathology and genetics of head and neck tumours. International Agency for Research on Cancer Publications, Lyon
4. Bashirova AA,MartinMP,McVicarDW, CarringtonM(2006) The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu Rev Genomics Hum Genet 7:277-300
5. Boyton RJ, Altmann DM (2007) Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease. Clin Exp Immunol 149:1-8 (Pubitemid 46897116)
6. Campillo JA, Legaz I, Alvarez MRL, Bolarin JM, Heras BL, Muro M et al (2013) KIR gene variability in cutaneous malignant melanoma: influence of KIR2D/HLA-C pairings on disease susceptibility and prognosis. Immunogenetics 65:333-343
7. Cariani E, Pilli M, Zerbini A, Rota C, Olivani A, Zanelli P et al (2013) HLA and killer immunoglobulin-like receptor genes as outcome predictors of hepatitis C virus-related hepatocellular carcinoma. Clin Cancer Res 19:5465-5473
8. Carrington M, Norman P (2003) The KIR gene cluster. National Library of Medicine (US), National Center for Biotechnology Information, Bethesda
9. Cereb N, Maye P, Lee S, Kong Y, Yang SY (1995) Locus-specific amplification of HLA class I genes from genomic DNA: locus-specific sequences in the first and third introns of HLA-A, HLAB, and HLA-C alleles. Tissue Antigens 45:1-11
10. Du Z, Gjertson DW, Reed EF, Rajalingam R (2007) Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans. Immunogenetics 59:1-15 (Pubitemid 46011187)
11. Dutta A, Lourembam SD, Pradhan S, Baruah S (2013) KIR diversity in three ethnic populations of Assam state, Northeast India. Tissue Antigens 82:48-52
12. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) AJCC cancer staging manual, 7th edn. American Joint Committee on Cancer, Chicago
13. Guerini FR, Mancuso R, Agostini S, Agliardi C, ZanzotteraM, Hernis A et al (2012) Activating KIR/HLA complexes in classic Kaposi's sarcoma. Infect Agents Cancer 7:9
14. Hirayasu K, Ohashi J, Kashiwase K, Hananantachai H, Naka I, Ogawa A et al (2012) Significant association of KIR2DL3-HLA-C1 combination with cerebral malaria and implications for co-evolution of KIR and HLA. PLoS Pathog 8:e1002565
15. Hollenbach JA, Ladner MB, Saeteurn K, Taylor KD, Mei L, Haritunians T et al (2009) Susceptibility to Crohn 's disease is mediated by KIR 2DL2 / KIR 2DL3 heterozygosity and the HLA-C ligand. Immunogenetics 61:663-671
16. Imbeaud S, Graudens E, Boulanger V, Barlet X, Zaborski P, Eveno E et al (2005) Towards standardization of RNA quality assessment using user-independent classifiers ofmicrocapillary electrophoresis traces. Nucleic Acids Res 33:e56
17. Khakoo SI, Thio CL,MartinMP, Brooks CR, Gao X, Astemborski J et al (2004) HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305:872-874 (Pubitemid 39038423)
18. Koehler RN,Walsh AM, MoqueetN, Currier JR, EllerMA, Eller LA et al (2009) High-through put genotyping of KIR2DL2/L3, KIR3DL1/ S1, and their HLA class I ligands using real-time PCR. Tissue Antigens 74:73-80
19. Kovacic MB, Martin M, Gao X, Fuksenko T, Chen CJ, Cheng YJ et al (2005) Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 14:2673-2677 (Pubitemid 41752733)
20. Kulkarnia S, Martin MP, Carrington M (2008) The ying and yang of HLA and KIR in human disease. Semin Immunol 20:343-352
21. Kusnierczyk P (2013) Killer cell immunoglobulin-like receptor gene associations with autoimmune and allergic diseases, recurrent spontaneous abortion, and neoplasms. Front Immunol 4:8
22. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative pcr and the 2-ΔΔCTT method. Methods 25:402-408 (Pubitemid 34164012)
23. Masilamani M, Nguyen C, Kabat J, Borrego F, Coligan JE (2006) CD94/NKG2A Inhibits NK cell activation by disrupting the actin network at the immunological synapse. J Immunol 177: 3590 -3596
24. Moesta AK, Parham P (2012) Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3. Front Immunol 3:336
25. Nemesure B, Wu SY, Hennis A, Leske MC (2013) Family history of prostate cancer in a Black population. J Immigr Minor Health 15: 1107-1112
26. Pan N, Jiang W, Sun H, Miao F, Qiu J, Jin H et al (2011) KIR and HLA loci are associated with hepatocellular carcinoma development in patients with hepatitis B virus infection: a case-control study. PLoS One 6:e25682
27. Pan N, Qiu J, Sun H, Miao F, Shi Q, Xu J, et al. (2013) Combination of human leukocyte antigen and killer cell immunoglobulin-like receptor genetic background influences the onset age of hepatocellular carcinoma in male patients with hepatitis B virus infection. Clin. Dev. Immunol. 7 pages
28. Parham P, Moffett A (2013) Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution. Nat Rev Immunol 13:133-144
29. Parham P, Norman PJ, Rached LA, Guethlein LA (2012) Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules. Phil Trans R Soc B 367:800-811
30. Purdy AK, Campbell KS (2009) Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR). Cancer Biol Ther 8:13-22